GPCM
KURA icon

Granite Point Capital Management’s Kura Oncology KURA Stock Holding History

Granite Point Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,000
Closed -$310K – 77
2022
Q4 		$310K Buy
+25,000
New +$363K 0.2% 72

Other funds holding KURA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Granite Point Capital Management's KURA Position: Q1 2023 in Review

Granite Point Capital Management sold out of Kura Oncology (KURA) in Q1 2023, closing a stake of 25,000 shares — an estimated $310K sold.

Granite Point Capital Management first reported a position in KURA in Q4 2022 and held it in 1 quarter. The position peaked at $310K in Q4 2022. 141 funds tracked by Wall St. Rank hold KURA as of Q1 2023.

  • Granite Point Capital Management reported no remaining Kura Oncology position as of Q1 2023 after selling out during the quarter.
  • Granite Point Capital Management sold 25,000 Kura Oncology shares in Q1 2023, an estimated $310K.
  • Granite Point Capital Management first reported a position in Kura Oncology in Q4 2022 and held it in 1 quarter.
  • Granite Point Capital Management's Kura Oncology position peaked at $310K in Q4 2022.
  • 141 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2023.

Based on Granite Point Capital Management's 13F filing for Q1 2023, filed 11 May 2023.